Monday, September 14, 2026
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO NA Magazine > News > CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims

CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims

in News
CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims
Share on LinkedinShare on WhatsApp

CVS Health, Walgreens Boots Alliance and Walmart have agreed to pay about $13.8 billion to resolve thousands of lawsuits accusing the pharmacy chains of mishandling opioid painkillers.

In a filing with the Securities and Exchange Commission Walgreens disclosed that it had agreed to pay about $5.7 billion over 15 years. CVS said Wednesday it had agreed to pay about $5 billion over 10 year and Walmart has agreed to pay $3.1 billion, according to two people familiar with the matter.

Neither company admitted wrongdoing.

CVS, Walgreens and Walmart are the three largest retail pharmacies in the country by market share.

“We are pleased to resolve these longstanding claims and putting them behind us is in the best interest of all parties, as well as our customers, colleagues and shareholders,” CVS’s general counsel, Thomas Moriarty, said in a statement. The company did not admit wrongdoing.

Walgreens said in its SEC filing that it “continues to believe it has strong legal defenses” and will defend itself against any future lawsuits not covered by the settlement.

In more than 3,300 lawsuits, beginning in 2017, state and local governments accused drugmakers of downplaying the risks of their opioid pain medicines. Pharmacies were accused of ignoring red flags that prescriptions were being diverted into illegal trafficking.

Overdoses involving opioids, including prescription pills and heroin, surged further during the Covid pandemic, increasing 38% in 2020 over the previous year and another 15% in 2021, according to the Centers for Disease Control and Prevention.

Tags: CVS HealthopioidsWalgreensWalmart

Related Posts

Market reacts to Trump’s Treasury pick
News

Dollar steadies as diesel hits $6

Ford CEO: Company will rethink electric vehicle strategies
News

Ford announces $1 billion Kentucky investment

Oracle announces 9% revenue growth in Q2 results
News

Oracle rises on triple-digit growth in cloud infrastructure

Amazon Reports Significant Loss in Quarterly Results
News

Cybersecurity expert Kevin Mandia joins Amazon’s Board of Directors

Taiwanese chipmaking giant TSMC to invest $100 billion in U.S.
News

TSMC revenue surges over 53%

Nvidia reveals new H200 chip for AI training
News

DOJ investigates Nvidia’s licensing deal with Groq

Google shares details of AI chips, Arm-based central processor
News

Google to invest $15 billion in AI infrastructure

Canadian Trade Minister warns Canada has retaliatory plan to trade tariffs
News

U.S. extends ban on Canadian goods amid escalating trade war

Southwest reaches new contract with pilots
News

Brent crude exceeds $100 a barrel as Middle East conflict escalates

WaFd and EverBank enter into $3.9 billion merger
News

WaFd and EverBank enter into $3.9 billion merger

No Result
View All Result

Recent Posts

  • Want Your Kids to Choose Healthy Foods? Here Are Some Research-Backed Tips
  • Artworks stolen from Renoir Museum
  • Dollar steadies as diesel hits $6
  • Ford announces $1 billion Kentucky investment
  • A 75-hour luxury train ride through the heart of Australia’s outback

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 2125 9933 0330

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 2125 9933 0330

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

CEO North America © 2024 - Sitemap

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.